Oct. 28, 2025 — QT Imaging Holdings, Inc., a medical device company focused on radiation-free imaging technology, has announced a strategic collaboration with Intelerad Medical Systems. The agreement establishes the deployment of InteleShare Research picture archiving and communication systems (PACS) and Cloud PACS across QT Imaging’s clinical research and commercial networks.
The collaboration supports QT Imaging’s mission to deliver safe, quantitative, and accessible imaging by enabling seamless integration of QT Imaging’s Breast Acoustic CT Scanners with InteleShare’s secure, cloud-based platform to deliver QT Imaging’s Cloud SaaS Platform to its customers. This will allow research institutions and clinical sites to upload, store, anonymize and share imaging data with improved efficiency, while maintaining compliance with the highest data privacy and security standards.
Under the scope of the partnership:
- InteleShare Research PACS will provide a browser-based viewer for physicians to access anonymized breast images, perform measurements, and manage multi-institutional research trials.
- InteleShare Cloud PACS will extend secure image archiving, exchange, and collaboration across QT Imaging’s commercial installations, enabling providers and patients to access imaging data anywhere, anytime.
Integrated workflows will streamline clinical trials, anonymization, and data exchange for QT Imaging’s research collaborations, as well as for its commercial customers.
QT Imaging’s Cloud SaaS Platform will also serve as the unified delivery framework for upcoming AI/ML algorithms developed by the company. Leveraging InteleShare’s DICOM-compatible architecture, QT Imaging will integrate these modules through the cloud for quantitative feature extraction and diagnostic decision support. Built on advanced acoustic signal analysis and volumetric data fusion, the algorithms will be deployed in real time through the cloud infrastructure. This will ensure that future AI-driven advancements, such as automated lesion segmentation, volumetric tissue characterization, and computer-aided diagnosis, can be securely delivered to all connected QTI Breast Acoustic CT systems without requiring on-premise updates.
"Our collaboration with Intelerad strengthens QT Imaging’s ability to deliver not only breakthrough breast imaging but also a modern, cloud-enabled infrastructure that accelerates research and supports clinical adoption," said Dr. Raluca Dinu, Chief Executive Officer of QT Imaging. "InteleShare platform is designed to serve the backbone for connecting our scanners with both research institutions and clinical sites, ensuring a seamless and secure experience for physicians and patients."
"We are excited to partner with QT Imaging to advance their mission of improving women’s health through innovation," said Morris Panner, President of Intelerad. "By leveraging InteleShare’s secure and scalable architecture, QT Imaging and its collaborators can focus on clinical research and patient outcomes while relying on robust image management capabilities."
The deployment will include implementation, training, and integration with electronic health record (EHR) systems, ensuring smooth adoption across QT Imaging’s partner network.
This collaboration builds on QT Imaging’s roadmap to expand access to its FDA-cleared Breast Acoustic CT Scanner, advance clinical trials, and accelerate commercialization of QTI’s Cloud SaaS platform globally.
Learn more at www.qtimaging.com.
July 07, 2026 
